Fibro Biologics, Inc. FBLG
We take great care to ensure that the data presented and summarized in this overview for FibroBiologics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FBLG
Top Purchases
Top Sells
About FBLG
Insider Transactions at FBLG
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Hamid Khoja Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+47.06%
|
$10,000
$1.9 P/Share
|
|
Aug 12
2024
|
Pete O'Heeron Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,500
+0.14%
|
$8,500
$1.91 P/Share
|
Last 12 Months Summary
Buy / Acquisition
18.5K
Shares
From
2
Insiders
| Open market or private purchase | 18.5K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders